Aduhelm and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aduhelm (aducanumab-avwa) and Ezetimibe (ezetimibe). Common drug interactions include cerebral haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Aduhelm and Ezetimibe. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Aduhelm?

Aduhelm has active ingredients of aducanumab-avwa. eHealthMe is studying from 520 Aduhelm users. Check the latest studies of Aduhelm.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.



On Jul, 16, 2026

11 people who take Aduhelm and Ezetimibe together, and have interactions are studied.

Aduhelm and Ezetimibe drug interactions.

What are the common drug interactions of Aduhelm and Ezetimibe, by gender? *:

female:

n/a

male:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Aphasia (damage to the parts of the brain that control language)
  3. Type 2 diabetes mellitus
  4. Chest pain
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Non-cardiac chest pain
  7. Prostate cancer
  8. Blood calcium increased
  9. Blood chloride decreased
  10. Blood urea increased

What are the common drug interactions of Aduhelm and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Prostate cancer
  3. Non-cardiac chest pain
  4. Blood calcium increased
  5. Blood chloride decreased
  6. Blood urea increased
  7. Hyperglycaemia (high blood sugar)
  8. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. White blood cell count increased

What are the existing conditions these people have? *

  1. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 11 people, 100.00%
  2. Incontinence (lack of moderation or self-control): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Aduhelm and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aduhelm and Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aduhelm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aduhelm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aducanumab-avwa and ezetimibe (the active ingredients of Aduhelm and Ezetimibe, respectively), and Aduhelm and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: